IMPRINT is a network focusing on maternal and neonatal immunisation, originally funded by the UK’s Global Challenges Research Fund (GCRF). Its members support challenge-led interdisciplinary research and aim to strengthen capacity for research and innovation within the UK and in low- and middle-income countries. IMPRINT is coordinated by Network Director Prof. Beate Kampmann (London School of Hygiene and Tropical Medicine) and Co-Director A/Prof. Chrissie Jones (University of Southampton).
IMPRINT brings together people working with PASSION
Over the last 5 years, IMPRINT has built a sustainable network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health and national and international policy makers, to tackle the challenges in the best use of vaccines in pregnancy and in newborns, and in the long term to improve maternal and newborn health. With over 300 members from 50 countries that all share the same passion for maternal immunisation, IMPRINT has quickly become a highly productive, multi-disciplinary and innovative network that continues to make an impact.
Why should we vaccinate pregnant women and how do these vaccines work? IMPRINT created a short animation to answer your questions around the main theme of our network.
We also produced a short animation on COVID-19 vaccines for pregnant and breastfeeding women. To watch this video and to learn more about IMPRINT, our mission and the people involved, follow the link below.
IMPRINT fellow Alansana Darboe from the MRC Unit The Gambia at the LSHTM and his team investigated interactions between Maternal IgG and Neonatal Innate Immune Cells.
IMPRINT fellow Neisha Sundaram from LSHTM completed her project on public, provider, policy and contextual factors for maternal vaccine acceptance.
Beth Holder from Imperial College London and her team studied the transplacental transfer of protective antibodies from mother to baby in pregnancy with human placental samples.